Alcon's board of directors has elected Daniel Vasella to be its new chairman. He steps in for Cary Rayment, who will stay on the board as its vice chairman. Vasella is also chairman at Novartis, which bought a majority of Alcon in August.
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.